Neurodevelopmental outcome at 42 months following thyroxine supplementation in infants below 28 weeks' gestation: a randomised controlled trial.
CONCLUSION Our data suggest that early supplementation with LT4 may improve long-term neurodevelopment in infants born below 28 weeks' gestation but larger trials are warranted as the current reported improvements shown are not strong enough to warrant a change in practice.
PMID: 32070246 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
More News: Brain | Disability | Endocrinology | Hormones | Levothyroxine | Men | Neurology | Perinatology & Neonatology | Synthroid | Thyroid | UK Health